Oncology

Ipsos’ #1 therapy area of focus

dna

The oncology treatment landscape continues to evolve at speed, creating knowledge gaps with each new fast-tracked approval and change in standard of care.  

At Ipsos, we speak oncology – thanks to dedicated custom oncology teams worldwide, oncology access and advisory expertise, and long-standing Global Healthcare Monitors offering market-leading oncology real-world evidence, validated prevalence figures, and other insights.

Additional focus on the use of molecular diagnostics provides further granularity into changing oncology treatment paradigms and individualised approaches.

Whatever your business question, our Oncology CoE ensures that the best expertise, insights and approaches from across the Ipsos globe are used to answer it.

Learn more  
Ipsos Global Oncology Monitor

Recent thought leadership  
PoV: Why are ADCs so Hot Right Now?
Webinar: Evaluating Time & Treatment While Living with Metastatic Breast Cancer
Paper & Podcast: Mastering Complexity: The Path to a Cancer-free Reality
Paper: Oncology: The Disease, Dynamics & Challenges of Marketing & MR  
ASCO 2023 Poster: Patient Access to Precision Medicine in NSCLC

 

Tell us your oncology business questions.

More insights about Health